104 related articles for article (PubMed ID: 22842949)
41. Phenotypic and genotypic characterization of Vibrio cholerae clinically isolated in Surabaya, Indonesia.
Nishibori T; de Vries GC; Rahardjo D; Wasito EB; De I; Kinoshita S; Hayashi Y; Hotta H; Kawabata M; Shirakawa T; Iijima Y; Osawa R
Jpn J Infect Dis; 2011; 64(1):7-12. PubMed ID: 21266749
[TBL] [Abstract][Full Text] [Related]
42. Distribution of class I integron and sulfamethoxazole trimethoprim constin in Vibrio cholerae isolated from patients in Iran.
Adabi M; Bakhshi B; Goudarzi H; Zahraei SM; Pourshafie MR
Microb Drug Resist; 2009 Sep; 15(3):179-84. PubMed ID: 19728775
[TBL] [Abstract][Full Text] [Related]
43. Haitian variant ctxB producing Vibrio cholerae O1 with reduced susceptibility to ciprofloxacin is persistent in Yavatmal, Maharashtra, India, after causing a cholera outbreak.
Kumar P; Mishra DK; Deshmukh DG; Jain M; Zade AM; Ingole KV; Yadava PK
Clin Microbiol Infect; 2014 May; 20(5):O292-3. PubMed ID: 24102849
[TBL] [Abstract][Full Text] [Related]
44. Cholera in Ethiopia in the 1990 s: epidemiologic patterns, clonal analysis, and antimicrobial resistance.
Scrascia M; Pugliese N; Maimone F; Mohamud KA; Ali IA; Grimont PA; Pazzani C
Int J Med Microbiol; 2009 Jun; 299(5):367-72. PubMed ID: 19121605
[TBL] [Abstract][Full Text] [Related]
45. Epidemics of severe cholera caused by El Tor Vibrio cholerae O1 Ogawa possessing the ctxB gene of the classical biotype in Orissa, India.
Pal BB; Khuntia HK; Samal SK; Kar SK; Patnaik B
Int J Infect Dis; 2010 May; 14(5):e384-9. PubMed ID: 19781971
[TBL] [Abstract][Full Text] [Related]
46. Emergence and spread of tetracycline resistant Vibrio cholerae O1 El Tor variant during 2010 cholera epidemic in the tribal areas of Odisha, India.
Kar SK; Pal BB; Khuntia HK; Achary KG; Khuntia CP
Int J Infect Dis; 2015 Apr; 33():45-9. PubMed ID: 25543097
[TBL] [Abstract][Full Text] [Related]
47. Clonal relationship among Vibrio cholerae O1 El Tor strains causing the largest cholera epidemic in Kenya in the late 1990s.
Scrascia M; Maimone F; Mohamud KA; Materu SF; Grimont F; Grimont PA; Pazzani C
J Clin Microbiol; 2006 Sep; 44(9):3401-4. PubMed ID: 16954285
[TBL] [Abstract][Full Text] [Related]
48. Origin of Vibrio cholerae in Haiti.
Ceccarelli D; Spagnoletti M; Cappuccinelli P; Burrus V; Colombo MM
Lancet Infect Dis; 2011 Apr; 11(4):262. PubMed ID: 21453867
[No Abstract] [Full Text] [Related]
49. Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand.
Siriphap A; Leekitcharoenphon P; Kaas RS; Theethakaew C; Aarestrup FM; Sutheinkul O; Hendriksen RS
PLoS One; 2017; 12(1):e0169324. PubMed ID: 28103259
[TBL] [Abstract][Full Text] [Related]
50. [Antimicrobial activity of Morinda morindoides on in vitro growth of vibrio cholerae in Côte d'Ivoire].
Koffi AE; Yapi HF; Bahi C; Guessend KN; Djaman JA; Guede-Guina F
Med Trop (Mars); 2010 Feb; 70(1):53-6. PubMed ID: 20337116
[TBL] [Abstract][Full Text] [Related]
51. Clonal relationship among Vibrio cholerae O1 El Tor strains isolated in Somalia.
Scrascia M; Pugliese N; Maimone F; Mohamud KA; Grimont PA; Materu SF; Pazzani C
Int J Med Microbiol; 2009 Mar; 299(3):203-7. PubMed ID: 18774337
[TBL] [Abstract][Full Text] [Related]
52. [Cholera in Rio Grande do Norte State--Brazil: sorology and sensitivity of Vibrio cholerae to different antimicrobials].
de Melo LM; Vieira RH; Hofer E; Batista AL; Almeida D
Acta Cir Bras; 2005; 20 Suppl 1():8-11. PubMed ID: 17768794
[TBL] [Abstract][Full Text] [Related]
53. Investigating the virulence genes and antibiotic susceptibility patterns of Vibrio cholerae O1 in environmental and clinical isolates in Accra, Ghana.
Abana D; Gyamfi E; Dogbe M; Opoku G; Opare D; Boateng G; Mosi L
BMC Infect Dis; 2019 Jan; 19(1):76. PubMed ID: 30665342
[TBL] [Abstract][Full Text] [Related]
54. Emergence of multiple drug resistance Vibrio cholerae O1 in East Delhi.
Das S; Choudhry S; Saha R; Ramachandran VG; Kaur K; Sarkar BL
J Infect Dev Ctries; 2011 Apr; 5(4):294-8. PubMed ID: 21537071
[TBL] [Abstract][Full Text] [Related]
55. Novel multiple mutations in the topoisomerase gene of Haitian variant Vibrio cholerae O1.
Divya MP; Sivakumar KC; Sarada Devi KL; Remadevi S; Thomas S
Antimicrob Agents Chemother; 2014 Aug; 58(8):4982-3. PubMed ID: 24867982
[No Abstract] [Full Text] [Related]
56. Epidemiology and Antibiogram Profile of Vibrio cholerae Isolates between 2004-2013 from Odisha, India.
Pal BB; Nayak SR; Khuntia HK
Jpn J Infect Dis; 2018 Mar; 71(2):99-103. PubMed ID: 29279443
[TBL] [Abstract][Full Text] [Related]
57. Methicillin-susceptible, doxycycline-resistant Staphylococcus aureus, Côte d'Ivoire.
Lesens O; Haus-Cheymol R; Dubrous P; Verret C; Spiegel A; Bonnet R; Bes M; Laurichesse H; Beytout J; Etienne J; Migliani R; Koeck JL;
Emerg Infect Dis; 2007 Mar; 13(3):488-90. PubMed ID: 17552109
[TBL] [Abstract][Full Text] [Related]
58. Spread of cholera with newer clones of Vibrio cholerae O1 El Tor, serotype inaba, in India.
Dutta B; Ghosh R; Sharma NC; Pazhani GP; Taneja N; Raychowdhuri A; Sarkar BL; Mondal SK; Mukhopadhyay AK; Nandy RK; Bhattacharya MK; Bhattacharya SK; Ramamurthy T
J Clin Microbiol; 2006 Sep; 44(9):3391-3. PubMed ID: 16954282
[TBL] [Abstract][Full Text] [Related]
59. Characterization of highly virulent multidrug resistant Vibrio cholerae isolated from a large cholera outbreak in Ghana.
Feglo PK; Sewurah M
BMC Res Notes; 2018 Jan; 11(1):45. PubMed ID: 29347965
[TBL] [Abstract][Full Text] [Related]
60. New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1.
Fonseca EL; Dos Santos Freitas F; Vieira VV; Vicente AC
Emerg Infect Dis; 2008 Jul; 14(7):1129-31. PubMed ID: 18598639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
